NCT01091818

Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children

A Prospective, Double-blind Study of Dexmedetomidine Versus Midazolam for Intensive Care Sedation of Children

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Ullevaal University Hospital · Academic / Other
• Sex: All
• Age: 2 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

Dexmedetomidine will be tested against midazolam in a prospective, randomized, double-blind study of intensive care children, age 2-17 years. The investigators' primary hypothesis is that time from end of medication to extubation will be shorter with dexmedetomidine sedation.

Conditions

• Sedation

Interventions

Type	Name	Description
DRUG	dexmedetomidine	Dexemedethomidine is given as major sedative drug
DRUG	Midazolam	Midazolam is given as major sedative drug

Timeline

• Start date: 2010-03-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2010-03-24
• Last updated: 2011-07-21

Locations

1 site across 1 country: Norway